<unk>  is an antineoplastic agent that is FDA approved for the treatment of patients with metastatic castration-resistant prostate cancer (CRPC).   Common adverse reactions include asthenia/fatigue, back pain, decreased appetite, constipation, arthralgia, diarrhea, hot flush, upper respiratory tract infection, peripheral edema, dyspnea, musculoskeletal pain, weight decreased(Weight Loss), headache, hypertension, and dizziness/vertigo..
Enzalutamide
Bicalutamide
Flutamide
Carbutamide
Apalutamide
Nilutamide
Tamoxifen
Ribociclib